These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19869869)

  • 21. A TYPE SPECIFIC SUBSTANCE DISTINCT FROM THE SPECIFIC CARBOHYDRATE IN PNEUMOCOCCUS TYPE I.
    Enders JF
    J Exp Med; 1930 Jul; 52(2):235-52. PubMed ID: 19869762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : IV. THE SYNTHESIS OF THEp-AMINOBENZYL ETHER OF THE SOLUBLE SPECIFIC SUBSTANCE OF TYPE III PNEUMOCOCCUS AND ITS COUPLING WITH PROTEIN.
    Goebel WF; Avery OT
    J Exp Med; 1931 Jul; 54(3):431-6. PubMed ID: 19869929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STUDIES ON PNEUMOCOCCUS IMMUNITY : II. ACTIVE IMMUNIZATION OF MONKEYS AGAINST PNEUMOCOCCUS TYPES II, III, AND IV PNEUMONIA WITH THE HOMOLOGOUS PNEUMOCOCCUS VACCINE.
    Cecil RL; Steffen GI
    J Exp Med; 1923 Jul; 38(2):149-61. PubMed ID: 19868780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPECIFIC CUTANEOUS REACTIONS AND CIRCULATING ANTIBODIES IN THE COURSE OF LOBAR PNEUMONIA : I. CASES RECEIVING NO SERUM THERAPY.
    Finland M; Sutliff WD
    J Exp Med; 1931 Oct; 54(5):637-52. PubMed ID: 19869947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some biological properties of Pneumococcus type 37 and the chemistry of its capsular polysaccharide.
    Knecht JC; Schiffman G; Austrian R
    J Exp Med; 1970 Sep; 132(3):475-87. PubMed ID: 4399979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : V. THE IMMUNOLOGICAL SPECIFITY OF AN ANTIGEN PREPARED BY COMBINING THE CAPSULAR POLYSACCHARIDE OF TYPE III PNEUMOCOCCUS WITH FOREIGN PROTEIN.
    Avery OT; Goebel WF
    J Exp Med; 1931 Jul; 54(3):437-47. PubMed ID: 19869930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CUTANEOUS REACTIONS TO THE POLYSACCHARIDES AND PROTEINS OF PNEUMOCOCCUS IN LOBAR PNEUMONIA.
    Tillett WS; Francis T
    J Exp Med; 1929 Oct; 50(5):687-701. PubMed ID: 19869655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A "SOLUBLE SPECIFIC SUBSTANCE" DERIVED FROM GUM ARABIC.
    Heidelberger M; Avery OT; Goebel WF
    J Exp Med; 1929 Apr; 49(5):847-57. PubMed ID: 19869586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CUTANEOUS REACTIONS IN RABBITS TO THE TYPE-SPECIFIC CAPSULAR POLYSACCHARIDES OF PNEUMOCOCCUS.
    Francis T; Tillett WS
    J Exp Med; 1931 Sep; 54(4):587-96. PubMed ID: 19869942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. THE CHARACTER OF THE PNEUMONIC LESIONS PRODUCED BY INTRABRONCHIAL INSUFFLATION OF VIRULENT STREPTOCOCCI.
    Wollstein M; Meltzer SJ
    J Exp Med; 1913 Nov; 18(5):548-55. PubMed ID: 19867729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : III. CHEMICAL AND IMMUNOLOGICAL PROPERTIES OF THE SPECIES-SPECIFIC SUBSTANCE.
    Lancefield RC
    J Exp Med; 1928 Feb; 47(3):481-91. PubMed ID: 19869425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. THE IMMUNOLOGICAL RELATIONSHIP OF THE CAPSULAR POLYSACCHARIDE OF TYPE XIV PNEUMOCOCCUS TO THE BLOOD GROUP A SPECIFIC SUBSTANCE.
    Beeson PB; Goebel WF
    J Exp Med; 1939 Aug; 70(3):239-47. PubMed ID: 19870905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus.
    Winkelstein JA; Bocchini JA; Schiffman G
    J Immunol; 1976 Feb; 116(2):367-70. PubMed ID: 2634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. THE IMMUNOLOGICAL PROPERTIES OF THE HETEROPHILE ANTIGEN AND SOMATIC POLYSACCHARIDE OF PNEUMOCOCCUS.
    Goebel WF; Adams MH
    J Exp Med; 1943 May; 77(5):435-49. PubMed ID: 19871295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of a prosthetic group in a type-specific polysaccharide of pneumococcus.
    HEIDELBERGER M; MacLEOD CM; MARKOWITZ H; DiLAPI MM
    J Exp Med; 1951 Nov; 94(5):359-62. PubMed ID: 14888817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. THE ROLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPES II AND III.
    Ross V
    J Exp Med; 1932 Jan; 55(1):1-12. PubMed ID: 19869968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STUDIES ON NATURAL IMMUNITY TO PNEUMOCOCCUS TYPE III : IV. OBSERVATIONS ON A NON-TYPE SPECIFIC HUMORAL FACTOR INVOLVED IN RESISTANCE TO PNEUMOCOCCUS TYPE III.
    Enders JF; Wu CJ; Shaffer MF
    J Exp Med; 1936 Aug; 64(3):425-38. PubMed ID: 19870545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. METABOLISM OF S AND R FORMS OF PNEUMOCOCCUS.
    Finkle P
    J Exp Med; 1931 Apr; 53(5):661-76. PubMed ID: 19869872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STUDIES ON OXIDATION AND REDUCTION BY PNEUMOCOCCUS : VII. ENZYME ACTIVITY OF STERILE FILTRATES OF AEROBIC AND ANAEROBIC CULTURES OF PNEUMOCOCCUS.
    Neill JM; Avery OT
    J Exp Med; 1924 Sep; 40(4):423-7. PubMed ID: 19868929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: Induction of transformation by a desoxyribonucleic acid fraction isolated from Pneumococcus type III. Oswald Theodore Avery (1877-1955).
    Avery OT; Macleod CM; McCarty M
    Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S3-8. PubMed ID: 11039746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.